SFM
LRMR icon

Sphera Funds Management’s Larimar Therapeutics LRMR Stock Holding History

Sphera Funds Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Buy
+926,004
New +$3.68M 0.37% 82
2025
Q4 		– Sell
-260,385
Closed -$841K – 117
2025
Q3 		$841K Buy
260,385
+63,750
+32% +$239K 0.18% 98
2025
Q2 		$568K Sell
196,635
-169,669
-46% -$393K 0.13% 98
2025
Q1 		$788K Sell
366,304
-89,300
-20% -$282K 0.18% 98
2024
Q4 		$1.76M Buy
455,604
+41,126
+10% +$271K 0.32% 84
2024
Q3 		$2.71M Buy
414,478
+102,009
+33% +$820K 0.43% 66
2024
Q2 		$2.27M Buy
+312,469
New +$2.39M 0.31% 86
2021
Q2 		– Sell
-100,000
Closed -$1.46M – 157
2021
Q1 		$1.46M Buy
+100,000
New +$1.82M 0.11% 132
2020
Q4 		– Sell
-342,064
Closed -$5.19M – 125
2020
Q3 		$5.19M Sell
342,064
-54,723
-14% -$693K 0.51% 58
2020
Q2 		$5.1M Buy
396,787
+133,323
+51% +$1.55M 0.48% 52
2020
Q1 		$2.43M Buy
263,464
+234,491
+809% +$3.08M 0.3% 51
2019
Q4 		$386K Buy
+28,973
New +$277K 0.03% 84
2019
Q1 		– Sell
-31,667
Closed -$1.88M – 115
2018
Q4 		$1.88M Sell
31,667
-4,166
-12% -$411K 0.21% 76
2018
Q3 		$5.03M Sell
35,833
-4,167
-10% -$506K 0.58% 47
2018
Q2 		$4.91M Buy
+40,000
New +$3.4M 0.68% 40
2015
Q4 		– Sell
-3,333
Closed -$1.28M – 125
2015
Q3 		$1.28M Buy
+3,333
New +$1.5M 0.16% 112
2015
Q1 		– Sell
-6,008
Closed -$2.22M – 160
2014
Q4 		$2.22M Sell
6,008
-2,084
-26% -$537K 0.38% 83
2014
Q3 		$1.91M Buy
+8,092
New +$1.83M 0.24% 92

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Sphera Funds Management's LRMR Position: Q2 2026 in Review

Sphera Funds Management opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 926,004 shares worth $2.82M. The stake represents 0.37% of the portfolio and ranks #82 among its holdings. This is a return to the name: Sphera Funds Management previously reported a position in LRMR as recently as Q3 2025.

Sphera Funds Management first reported a position in LRMR in Q3 2014 and has held it in 18 quarters since. The position peaked at $5.19M in Q3 2020. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Sphera Funds Management held 926,004 shares of Larimar Therapeutics worth $2.82M as of Q2 2026.
  • Larimar Therapeutics was a new Sphera Funds Management position in Q2 2026.
  • Larimar Therapeutics made up 0.37% of Sphera Funds Management's portfolio in Q2 2026, its #82 holding.
  • Sphera Funds Management first reported a position in Larimar Therapeutics in Q3 2014 and has held it in 18 quarters since.
  • Sphera Funds Management's Larimar Therapeutics position peaked at $5.19M in Q3 2020.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.